Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
Clinical trial NCT04871607 · RECRUITING
Trial details
- NCT number
- NCT04871607
- Sponsor
- City of Hope Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-02
- Primary completion
- 2029-10-02
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.